Weight gain in type 2 diabetes mellitus-Not all uphill

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages 128-132

  Cohen, Ohad ^a   Norymberg, Clara ^a   Neumann, Eylon ^a   Dekel, Hilla ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Type 2; Weight

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATIENT REFERRAL; SELF REPORT; WEIGHT GAIN; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; AGE OF ONSET; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; WEIGHT GAIN;

EID: 37549058035     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.07.010     Document Type: Article

References (16)

1. Anonymus Intensive, blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet 352 (1998) 837-853.
2. Mäkimattila S., Nikkilä K., and Yki-Järvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia 42 (1999) 406-412
3. Groop L. Different effects of insulin and oral antidiabetic agents on glucose and energy met abolism in type 2 diabetes mellitus. Diabetologia 32 (1989) 599-605
4. Yki-Jarvinen H., Ryysy L., Kauppila M., Kujansuu E., Lahti J., Marjanen T., et al. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82 (1997) 4037-4043
5. Franssila-Kallunki A., and Groop L. Factors associated with basal metabolic rate in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35 (1992) 962-966
6. U.K. Prospective Diabetes Study Group. U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44 (1995) 1249-1258.
7. Strowig S.M., and Raskin P. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus. Diabetes Obes. Metab. 7 (2005) 633-641
8. Inzuchi S.E. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 287 (2002) 360-372
9. Malone M., Alger-Mayer S.A., and Anderson D.A. Medications associated with weight gain. Ann. Pharmacother. 39 (2005) 2046-2054
10. Nichols G.A., and Gomez-Caminero A. Weight changes following the initiation of new anti-hyperglycaemic therapies. Diabetes Obes. Metab. 9 (2007) 96-102
11. de Fine Olivarius N., Andreasen A.H., Siersma V., Richelsen B., and Beck-Nielsen H. Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus. Diabetologia 49 (2006) 2058-2067
12. Chaudhry Z.W., Gannon M.C., and Nuttall F.Q. Stability of body weight in type 2 diabetes. Diabetes Care 29 (2006) 493-497
13. Looker H.C., Knowler W.C., and Hanson R.L. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 24 (2001) 1917-1922
14. Larger E., Rufat P., Dubois-Laforgue D., and Ledoux S. Insulin and weight gain: myth or reality?. Diabetes Metab. 27 (2001) S23-S27
15. Zangeneh F., Arora P.S., Dyck P.J., Bekris L., Lernmark A., Achenbach S.J., et al. Effects of duration of type 2 diabetes mellitus on insulin secretion. Endocr. Pract. 12 (2006) 388-393
16. Lafortuna C.L., Maffiuletti N.A., Agosti F., and Sartorio A. Gender variations of body composition, muscle strength and power output in morbid obesity. Int. J. Obes. (London) 29 (2005) 833-841